Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a med...
Publications
View AllAffiliated Researchers
Institution Info
- Type
- company
- Country
- US
- Publications
- 1
- Citations
- 5,513
External Links
Identifiers
- ROR
- https://ror.org/05fnzzk18